{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-25-003658","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2025-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.407752+00:00","generated_at":"2026-05-25T23:37:21.603615+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alzamend Neuro signs $5M financing with Orchid Finance; exchanges Series A pref for Series C with warrants","bullets":["Exchanges 97.75 Series A shares for 87.99 Series C shares; cancels existing 640K-share warrants.","Issues up to 500 Series C shares at $9,500 each for total gross proceeds of $5M (net $4.75M after 5% discount).","Series C carries 15% cumulative quarterly dividend, convertible at formula with $0.10 floor; warrants for 1M shares at $0.92125.","Tranche closings through Oct 2025; second tranche of 75 shares ($725K) due Apr 29 or 15 days post- registration effectiveness.","Stockholder approval required for issuances exceeding 19.99% of outstanding; ROFR and participation rights for investor after $712.5K funded."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-25-003658","json":"https://secwatch.observer/filing/0001214659-25-003658.json","markdown":"https://secwatch.observer/filing/0001214659-25-003658.md","text":"https://secwatch.observer/filing/0001214659-25-003658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925003658/0001214659-25-003658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925003658/z2272508k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T23:37:21.603615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}